Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
about
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
description
clinical trial
@en
ensayo clínico
@es
klinisch onderzoek
@nl
name
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
@en
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
@nl
type
label
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
@en
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
@nl
prefLabel
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
@en
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
@nl
P921
P1476
Phase IV Study for Efficacy an ...... ents With Hypercholesterolemia
@en
P17
P3098
NCT04397653
P4844
P580
2020-05-04T00:00:00Z
P582
2020-11-19T00:00:00Z